1456PPhase IV, open-label, multicentre trial of afatinib in...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1456PPhase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results

Reckamp, K L, Gilman, P, Halmos, B, Jahanzeb, M, McCann, J, Paripati, H, Seneviratne, L C, Wallace, J A, Rueter, B, Esler, A, Dowling, E, Koczywas, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy292.078
Date:
October, 2018
File:
PDF, 78 KB
2018
Conversion to is in progress
Conversion to is failed